Gene Therapy:

Manufacturing

Across indications, uniQure has built the world's leading gene therapy platform.

uniQure produces its AAV-based gene therapies in our own facilities with our proprietary manufacturing process, which uses insect cells and baculoviruses, a common family of viruses found in invertebrates. The Company's manufacturing capabilities may also make us an attractive collaborator for academic research institutions and biotechnology and pharmaceutical companies seeking to advance their programs into larger, late-stage clinical trials that require commercial-scale manufacturing. The Company has built a 55,000 square foot, state-of-the-art manufacturing facility in Lexington, Massachusetts, USA.

Gene therapy manufacturing sidebar

 

Join us for a video walkthrough and discussion about our Lexington manufacturing facility.